Skip to main content

Table 3 Characteristics of the surviving patients who were included in the final analysis

From: Influences of changes in obesity-related parameters on progression of arteriosclerosis in hemodialysis patients: a prospective cohort study

  Baseline Study end
Number of patients 102
Age (years) 65.4 ± 12.1
Gender (m/f) 54/48
Body mass index (kg/m2) 22.4 ± 3.0 22.2 ± 3.3
Dialysis history (months) 66.4 ± 57.6
Diabetes (%) 42 (41)
Hyperlipidemia drugs (%) 10 (9.8)
Systolic BP (mmHg) 145 ± 22 145 ± 21
Diastolic BP (mmHg) 79 ± 12 77 ± 13
Laboratory study
 Hemoglobin (g/dl) 10.9 ± 0.9
 High-density lipoprotein cholesterol (mg/dl) 47.9 ± 16.0
 Low-density lipoprotein cholesterol (mg/dl) 86.1 ± 28.4
 Triglyceride (mg/dl) 96.9 ± 54.0
 Uric acid (mg/dl) 7.3 ± 1.2
 Creatinine (mg/dl) 10.2 ± 2.6
 C-reactive protein (mg/dl) 0.25 ± 0.70
 Ca (mg/dl) 8.9 ± 0.6
 Inorganic phosphorus (mg/dl) 5.1 ± 1.1
 Intact parathyroid hormone (pg/ml) 129.6 ± 82.8
 Albumin (g/dl) 3.7 ± 0.3
 Hemoglobin A1c (%) 5.23 ± 0.75
 Human atrial natriuretic polypeptide (pg/ml) 62.7 ± 63.5
 Brain natriuretic peptide (pg/ml) 214.3 ± 263.5
Cardiothoracic ratio (%) 51.7 ± 4.8
Brachial-ankle pulse wave velocity (cm/s) 1913 ± 446 2029 ± 546
Abdominal circumference (cm) 83.4 ± 8.6 82.6 ± 9.4
Visceral fat area (cm2) 86.2 ± 54.4 85.7 ± 54.0
Subcutaneous fat area (cm2) 120.1 ± 62.7 117.9 ± 60.2
  1. Values are expressed as mean ± SD